These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11888266)

  • 1. Oxcarbazepine.
    Schulze-Bonhage A; Homberg V
    Seizure; 2002 Jan; 11(1):73. PubMed ID: 11888266
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyponatremia from oxcarbazepine and carbamazepine.
    Dong X; Leppik IE; White J; Rarick J
    Neurology; 2005 Dec; 65(12):1976-8. PubMed ID: 16380624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ad hoc change from carbamazepine to oxcarbazepine--effectiveness and tolerance. A retrospective analysis].
    Homberg V; Kowalik A; Schulze-Bonhage A
    Nervenarzt; 2001 Dec; 72(12):918-23. PubMed ID: 11789435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.
    Ficker DM; Privitera M; Krauss G; Kanner A; Moore JL; Glauser T
    Neurology; 2005 Aug; 65(4):593-5. PubMed ID: 16116122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic drug monitoring of oxcarbazepine].
    Bouquié R; Dailly E; Bentué-Ferrer D;
    Therapie; 2010; 65(1):61-5. PubMed ID: 20205998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
    Mogensen PH; Jórgensen L; Boas J; Dam M; Vesterager A; Flesch G; Jensen PK
    Acta Neurol Scand; 1992 Jan; 85(1):14-7. PubMed ID: 1546529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures.
    Kruszewski SP; Klotz SG
    Neurology; 2007 Feb; 68(6):472; author reply 472-3. PubMed ID: 17283329
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-dependent oxcarbazepine-related anorgasmia.
    Calabrò RS; Ferlazzo E; Italiano D; Bramanti P
    Epilepsy Behav; 2010 Feb; 17(2):287-8. PubMed ID: 20089459
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse effects of antiepileptic drugs on bone mineral density.
    Babayigit A; Dirik E; Bober E; Cakmakci H
    Pediatr Neurol; 2006 Sep; 35(3):177-81. PubMed ID: 16939856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
    Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine versus carbamazepine treatment and induction of serum lipid abnormalities.
    Papacostas S
    J Child Neurol; 2000 Feb; 15(2):138-40. PubMed ID: 10695903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.
    Marson AG; Williamson PR; Taylor S; Maguire M; Chadwick DW
    Neurology; 2006 Nov; 67(10):1872-5. PubMed ID: 17130429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Old versus new antiepileptic drugs: the SANAD study.
    Perucca E; Alexandre V; Tomson T
    Lancet; 2007 Jul; 370(9584):313; author reply 315-6. PubMed ID: 17662870
    [No Abstract]   [Full Text] [Related]  

  • 14. Active control trials for epilepsy: avoiding bias in head-to-head trials.
    French JA; Kryscio RJ
    Neurology; 2006 May; 66(9):1294-5. PubMed ID: 16682655
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine-induced hyponatremia, a cross-sectional study.
    Nielsen OA; Johannessen AC; Bardrum B
    Epilepsy Res; 1988; 2(4):269-71. PubMed ID: 3197696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
    Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
    Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
    Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ
    Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy.
    Striano S; Striano P; Di Nocera P; Italiano D; Fasiello C; Ruosi P; Bilo L; Pisani F
    Epilepsy Res; 2006 May; 69(2):170-6. PubMed ID: 16515857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The trials and tribulations of pediatric drug trials.
    Shinnar S; Pellock JM
    Neurology; 2005 Nov; 65(9):1348-9. PubMed ID: 16275818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.